ISAP is a 501(c)(3) nonprofit organization which makes donations tax-deductible.
$5000 and above
Sorin Brull, MD, FCARCSI
Pam Flood, MD
Steve Shafer, MD
$1000 to $4999
Mark Dershwitz, MD
Joseph Foss, MD
Ken Johnson, MD
$500 to $999
Stuart Forman, MD
Elise Hyman & Family
Hugo Vereecke, MD
Thomas Henthorn, MD
Jonathan Moss, MD, PhD
Elie Sarraf, MD
Franklin Dexter, MD PhD
Jennifer Margaret Hunter, MB, ChB PhD FRCA FCARCSI
George Kracke, PhD
James Philip, ME(E), MD
Jijun Xu, MD, PhD
ISAP Announces the Inaugural Mohamed Naguib, MD Lecture and Posthumous Awarding of the ISAP Lifetime Achievement Award
Generous support provided by Senzime Corporation
In honor of Dr. Mohamed Naguib’s long service to the International Society of Anaesthetic Pharmacology (ISAP), and his distinguished contributions to the field of anesthesiology, he will posthumously receive the ISAP Lifetime Achievement Award. The award will be presented at the ISAP Annual Meeting on Saturday, October 2, 2021.
ISAP has established the Mohamed Naguib Lecture to honor his many accomplishments, which will be presented at every ISAP Annual Meeting. The Inaugural Lecture will be given at the 2021 ISAP Annual Meeting. ISAP has established a fund to endow the Mohamed Naguib Lecture and donations may be made at isaponline.org.
In the world of clinical pharmacology, Dr. Naguib was a renaissance man. As a man of many talents, his influential work has provided direction in many spheres of investigation and discovery. He made significant contributions to the scientific foundation and clinical applications of neuromuscular monitoring. He formed and led a coalition of thought leaders to prepare and disseminate expert consensus guidelines on neuromuscular monitoring. He had substantial interest in the mechanisms of and treatment for neuropathic pain. He led a laboratory that created molecules to treat neuropathic pain. At the time of his passing, he was a principal investigator on NIH funded multi-center observational study focused on the discovery and validation of a biomarker signature for chemotherapy induced peripheral neuropathic pain. He was the co-founder of a company that is developing a novel therapy for neuropathic pain and Alzheimer’s disease based on his research on the mechanisms of neuroinflammation. For each of these activities, he created a wake of opportunities for many that continue to have a vibrant and productive future. He was a prolific writer. He was the principal author or co-author of 130 peer-reviewed journal articles, 25 book chapters (including the premier Miller’s Textbook of Anesthesia) and 150 abstracts.
By way of professional service, for years, he served on the editorial board of numerous anesthesia journals and was influential not only in his reviews but in preparing thought provoking editorials and commentary. He also served for many years in various leadership positions, including president of ISAP.
Dr. Naguib was graduated from the Cairo University, College of Medicine, in 1976 and finished his anesthesia residency in 1981. He served as a Post-Doctoral Research Fellow in the Department of Anesthesiology, University of California, San Diego, California. In 1992 he joined the Department of Anesthesia at the College of Medicine, King Saud University. In 1998 he joined the University of Texas MD Anderson Cancer Center in Houston. His last position was the 2010 appointed as Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
“Mohamed was a nationally and internationally renowned anesthesiologist who exemplified the career of a successful academic physician. To us, he was a colleague, a friend, and a mentor,” says Maged Argalious, MD, Chair of the Department of General Anesthesiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Naguib passed away on February 16, 2019.